FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Powered by Google
 

Meeting Summary: Drug Safety Oversight Board Off-Site
The National Labor College - George Meany Center
Silver Spring, Maryland
December 18, 2008

Public Summary

  • The Executive Director updated the Board on Public Health Advisories (PHAs), Early Communications about Ongoing Safety Reviews (ECs) and Information for Healthcare Professionals (HCP) sheets posted since the October 16, 2008 meeting (all available at http://www.fda.gov/cder/drug/DrugSafety/DrugIndex.htm) and those in development.

  • The Drug Safety Oversight Board discussed its role in how FDA should communicate drug safety information and its future role in improving communications (e.g., a more proactive communication strategy). Included were discussions of how the various Board functions relate to the new drug safety initiatives at FDA and how a partnership with the Board could facilitate these initiatives.

 

to top arrow Back to Top     back arrow DSOB Meeting Summaries

PDF document PDF requires the free Adobe Acrobat Reader

Date created: January 14, 2009